FIELD: medicine, pharmacy. SUBSTANCE: invention describes solid and liquid pharmaceutical medicinal forms comprising silanzetron or its additive acid salts as active component that contain physiologically tolerant water-soluble acid addition taken in the amount to provide stabilization of silanzetron in regard to racemization reaction. Addition is taken among mono- or polybasic organic acids with 2-12 carbon atoms and with the first value pKk between 1.1 and 4.8, acid salts of polybasic the above mentioned organic acids and among acid salts of polybasic mineral acids with the first value pKk between 1.5 and 7.5. Then invention describes the application of acid additions for stabilization of silanzetron in regard to racemization in pharmaceutical medicinal forms and method of preparing solid pharmaceutical medicinal forms. Silanzetron in pharmaceutical medicinal forms is stabilized with respect to racemization. EFFECT: improved properties of medicinal forms. 16 cl, 6 tbl
Title |
Year |
Author |
Number |
DERIVATIVES OF 10,13,15-TRIOXATRICYCLO-9.2.1.1.-PENTADECANONE, METHOD OF THEIR SYNTHESIS AND MEDICINAL AGENTS CONTAINING THESE COMPOUNDS |
1997 |
- Khelt'E Dagmar
- Projshoff Ul'F
- Ehkkhout Kristian
- Finner Ehmil'
|
RU2181727C2 |
DERIVATIVES OF UREA, METHOD OF THEIR SYNTHESIS (VARIANTS) AND MEDICINAL AGENT |
1998 |
- Zhasseran Daniel'
- Dehvid Samuehl'
- Antel' Jokhen
- Brjukner Rajnkhard
- Ehkkhout Kristian
- Bilenberg Gerkhard-Vil'Khel'M
|
RU2198883C2 |
METHOD TO OBTAIN ESTROGENS FROM MARE'S URINE |
1996 |
- Ban Ivan
- Borkhers Fridrikh
- Khajnemann Khenning
- Rashe Khajnts-Khel'Mer
|
RU2179029C2 |
DERIVATIVES OF BENZAZEPINON-N-ACETIC ACID SUBSTITUTED WITH PHOSPHONIC ACID, METHOD FOR THEIR PREPARING AND MEDICINAL AGENTS CONTAINING THESE COMPOUNDS |
1998 |
- Val'Dek Kharal'D
- Majl' Jorg
- Tormelen Dirk
- Vurl' Mikhel'
|
RU2211219C2 |
METHOD TO ISOLATE ESTROGENS FROM MARE'S URINE |
1996 |
- Ban Ivan
- Khajnemann Khenning
- Mekhtol'D Gerkhard
- Rashe Khajnts-Khel'Mer
|
RU2179028C2 |
ANTIHYPERGLYCAEMIC ACTIVITY OF PHARMACEUTICAL COMPOSITION |
1995 |
- Ehl'Bert Kaan
- Diter Tsigler
- Rajnkhard Brjukner
|
RU2145857C1 |
DRUGS CONTAINING DERIVATIVES OF IMIDAZOLE-1-YL |
1993 |
- Kristian Eekkhout
- Ul'F Projshoff
- Samuel' David
|
RU2125877C1 |
8-{4-[3-(5-FLUORO-1H-INDOL-3-YL)PROPYL]PIPERAZIN-1-YL}-2-METHYL-4H-BENZO[1,4]OXAZINE-3-ONE MESYLATE WITH HIGH AFFINITY TO DOPAMINE RECEPTOR D AND SEROTONIN REUPTAKE SITE |
2002 |
|
RU2281945C2 |
ORAL COMPOSITION COMPRISING DIFFICULTLY WATER-SOLUBLE ACTIVE SUBSTANCE SOLID SOLUTION |
2003 |
|
RU2314811C2 |
DERIVATIVES OF 11-ACETYL-12,13-DIOXABICYCLO[8,2,1]- TRIDECENONE, METHOD FOR THEIR PREPARING AND MEDICINAL AGENT COMPRISING THESE COMPOUNDS |
1999 |
- Zhasseran Daniel'
- Projshoff Ul'F
- Ehkkkhaut Kristian
|
RU2218346C2 |